Companies
Johnson & Johnson
S&P 500Health Care· USA

JNJ

Status-Quo-Player

Johnson & Johnson

UMDSQP

$237.96

-0.20%

Open $237.71·Prev $238.43

as of 13 Apr

STATUS-QUO-PLAYER

Power Core

The moat: JNJ's power derives from being the only company simultaneously entrenched at institutional scale in both pharmaceutical innovation and surgical technology, creating a dual-vertical counterparty position that no competitor can replicate.

Published1 Apr 2026
UniverseS&P 500
SectorHealth Care

Direction of Movement

Lateral With Upward Optionality Pending Key Catalysts

ROC 200

+56.6%

This page is for informational purposes only and does not constitute investment advice. L17X Research is an independent research service.
JNJ — Johnson & Johnson — Power Mapping Analysis — L17X — L17X